IL-5 and eotaxin levels in middle ear effusion and blood from asthmatics with otitis media with effusion

Acta Oto-Laryngologica

Volumn 123, Issue 3, 2003, Pages 383-387

  Nonaka, Manabu ^a   Fukumoto, Akira ^a   Ozu, Chika ^a   Mokuno, Eriko ^a   Baba, Shunkichi ^a   Pawankar, Ruby ^a   Yagi, Toshiaki ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Asthma; Eotaxin; IL 5; Otitis media with effusion

Indexed keywords

EOTAXIN; INTERLEUKIN 5;

ADULT; AGED; ARTICLE; ASTHMA; BLOOD SAMPLING; CELL INFILTRATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL; EOSINOPHILIA; FEMALE; HUMAN; MALE; MEASUREMENT; MIDDLE EAR EFFUSION; PRIORITY JOURNAL; SECRETORY OTITIS MEDIA; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ADULT; AGED; ASTHMA; CASE-CONTROL STUDIES; CHEMOKINES, CC; EAR, MIDDLE; ENZYME-LINKED IMMUNOSORBENT ASSAY; EOSINOPHILS; FEMALE; HUMANS; INTERLEUKIN-5; MALE; MIDDLE AGED; OTITIS MEDIA WITH EFFUSION;

EID: 0037277477     PISSN: 00016489     EISSN: None     Source Type: Journal    
DOI: 10.1080/0036554021000028117     Document Type: Article

References (24)

1. Hurst DS. Association of otitis media with effusion and allergy as demonstrated by intradermal skin testing and eosinophil cationic protein levels in both middle ear effusions and mucosal biopsies. Laryngoscope 1996; 106: 1128-37.
2. Hurst DS, Venge P. The presence of eosinophil cationic protein in middle ear effusion. Otolaryngol Head Neck Surg 1993; 108: 711-22.
3. Hurst DS, Fredence K. Eosinophil cationic protein in mucosal biopsies from patients with allergy and otitis media with effusion. Otolaryngol Head Neck Surg 1997; 117: 42-8.
4. Wright ED, Hurst D, Miotto D, et al. Increased expression of major basic protein (MBP) and interleukin-5 (IL-5) in middle ear biopsy specimens from atopic patients with persistent otitis media with effusion. Otolaryngol Head Neck Surg 2000; 123: 533-8.
5. Mogi G, Suzuki M. The role of IgE-mediated immunity in otitis media: fact or fiction? Ann N Y Acad Sci 1997; 830: 61-9.
6. Collins PD, Marleau S, Griffith-Johnson DA, et al. Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo. J Exp Med 1995; 182: 1169-74.
7. Mould AW, Matthaei KI, Young IG, et al. Relationship between interleukin-5 and eotaxin in regulating blood and tissue eosinophilia in mice. J Clin Invest 1997; 99: 1064-71.
8. Hohki G, Terada N, Hamano N, et al. The effects of eotaxin on the surface adhesion molecules of endothelial cells and on eosinophil adhesion to microvascular endothelial cells. Biochem Biophys Res Commun 1997; 241: 136-41.
9. Peled A, Gonzalo JA, Lloyd C, et al. The chemotactic cytokine eotaxin acts as a granulocyte-macrophage colony-stimulating factor during lung inflammation. Blood 1998; 91: 1909-16.
10. Palframan RT, Collins PD, Williams TJ, et al. Eotaxin induces a rapid release of eosinophils and their progenitors from the bone marrow. Blood 1998; 91: 2240-8.
11. Cauna N, Hinderer KH, Manzetti GW, et al. Fine structure of nasal polyps. Ann Otol Rhinol Laryngol 1972; 81: 41-58.
12. Kakoi H, Hiraide F. Histological study of formation and growth of nasal polyps. Acta Otolaryngol (Stockh) 1987; 103: 137-44.
13. Tomioka S, Yuasa R, Iino Y. Intractable otitis media in cases with bronchial asthma. In: Mogi G, ed. Recent advances in otitis media with effusion. Proceedings of the Second Extraordinary International Symposium on Recent Advances on Otitis Media. Amsterdam: Kugler Publications, Inc., 1994: 183-6.
14. Morinaka S. Allergic otitis media with gelatinous mucoid fluid containing eosinophils. Otolaryngol Head Neck Surg 1996; 114: 665-8.
15. Lopez AF, Sanderson CJ, Gamble JR, et al. Recombinant human interleukin 5 is a selective activator of human eosinophil function. J Exp Med 1988; 167: 219-24.
16. Clutterbuck EJ, Hurst EM, Sanderson JC. Human interleukin-5 (IL-5) regulates the production of eosinophils in human bone marrow cultures: comparison and interaction with ILA, IL-3, IL-6 and GM-CSF. Blood 1989; 73: 1504-12.
17. Elsner J, Kapp A. Regulation and modulation of eosinophil effector function. Allergy 1999; 54: 15-26.
18. Humbert M, Ying S, Corrigan C, et al. Bronchial mucosal expression of the genes encoding chemokines RANTES and MCP-3 in symptomatic atopic and nonatopic asthmatics: relationship to the eosinophil-active cytokines interleukin (IL)-5, granulocyte macrophage-colony stimulating factor, and IL-3. Am J Respir Cell Mol Biol 1997; 16: 1-8.
19. Lamkhioued B, Renzi PM, Abi-Younes S, et al. Increased expression of eotaxin in bronchioalveolar lavage and airways of asthmatics contributes to the chemotaxis of eosinophils to the site of inflammation. J Immunol 1997; 159: 4593-601.
20. Szczeklik A, Sladek K, Dworski R, et al. Bronchial aspirin challenge causes specific eicosanoid response in aspirin-sensitive asthmatics. Am J Respir Crit Care Med 1996; 154: 1608-14.
21. Sousa AR, Lams BEA, Pfister R, et al. Expression of interleukin-5 and granulocyte-macrophage colony-stimulating factor in aspirin-sensitive and non-aspirin-sensitive asthmatic airways. Am J Respir Crit Care Med 1997; 156: 1384-9.
22. Bachert C, Gevaert P, van Cauwenberg P. Nasal polyposis - a new concept on the formation of polyps. A C I Int 1999; 11: 130-5.
23. Humbles AA, Conroy DM, Marleau S, et al. Kinetics of eotaxin generation and its relationship to eosinophil accumulation in allergic airways disease: analysis in a guinea pig model in vivo. J Exp Med 1997; 186: 601-12.
24. Gonzalo JA, Lloyd CM, Wen D, et al. The coordinated action of CC chemokines in the lung orchestrates allergic inflammation and airway hyperresponsiveness. J Exp Med 1998; 188: 157-67.